$1.95
0.063.17%
Last update: Oct 30, 6:39 PM
Alaunos Therapeutics Inc (TCRT) Stock Price, Quote, News & History
TCRTNASDAQ
Alaunos Therapeutics acquired Velaris and raised $350 million to advance clinical therapies for pulmonary arterial hypertension through 2029.
You can purchase shares of Alaunos Therapeutics (NASDAQ:TCRT) through any online brokerage.
Other companies in Alaunos Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Alaunos Therapeutics to provide a consensus price target.
The stock price for Alaunos Therapeutics (NASDAQ: TCRT) is $1.86 last updated October 30, 2026 at 6:39 PM EDT.
There are no upcoming dividends for Alaunos Therapeutics.
Alaunos Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Alaunos Therapeutics.
Alaunos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated...
